Medical technology developer Onkos Surgical has raised $17.6m from investors including 3D printing equipment provider 3D Systems.

The oncology drug developer has raised $92.5m in VC funding, $11.5m of which came from MedImmune Ventures, the CVC unit that now owns a 16.7% stake.

Boston Scientific has led a $23.1m series B round for Neurotronik, a medical device devloper focusing on patients suffering from heart failure.

The healthcare data platform developer has raised new funding from the six investors in its last round, including Merck Global Health Innovation Fund.

The oncology drug developer has raised $92.5m in VC funding, $11.5m of which came from MedImmune Ventures, the CVC unit that now owns a 16.7% stake.

Existing investor Lilly Asia Ventures returned to take part in a round that will support the late stage development and commercialisation of four vaccine candidates.

The genomics technology producer has boosted the size of the corporate venture capital unit it announced in April last year from $100m to $189m with a $250m ceiling.

Qiang Sen has welcomed back series A investor Legend Capital for a $14.5m round that will fund the expansion of its chain of community healthcare clinics.

Tonghua Dongbao Pharmaceutical and Legend Holdings are among the investors in a series B round for wearable medical device maker Zhejiang PocTech Medical.